Current status of Fusarium infection in human and animal

Asian Journal of Animal and Veterinary Advances

Volumn 6, Issue 3, 2011, Pages 201-227

  Jain, P K ^a   Gupta, V K ^a   Misra, A K ^b   Gaur, R ^c   Bajpai, V ^a   Issar, S ^a  

^a MODY UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

^b CENTRAL INSTITUTE FOR SUBTROPICAL HORTICULTURE   (India)

^c DR RAM MANOHAR LOHIA AVADH UNIVERSITY   (India)

Author keywords

Fusarium sp.; Human and animal infection; Mycoses

Indexed keywords

ANIMALIA; EUKARYOTA; FUNGI; FUSARIUM; FUSARIUM ANTHOPHILUM; FUSARIUM OXYSPORUM; FUSARIUM PROLIFERATUM; FUSARIUM SOLANI; FUSARIUM SP.; HEXAPODA; MAMMALIA;

EID: 77955021056     PISSN: 16839919     EISSN: None     Source Type: Journal    
DOI: 10.3923/ajava.2011.201.227     Document Type: Article

References (158)

1. Alastruey-Izquierdo, A., M. Cuenca-Estrella, A. Monzón, E. Mellado and J.L. Rodríguez-Tudela, 2008. Antifungal susceptibility profile of clinical Fusarium sp. isolates identified by molecular methods. J. Antimicrob. Chemother., 61: 805-809.
2. Alcazar-Fuoli, L., E. Mellado, A. Alastruey-Izquierdo, M. Cuenca-Estrella and J.L. Rodriguez-Tudela, 2008. Aspergillus section fumigati: Antifungal susceptibility patterns and sequence- based identification. Antimicrobial Agents Chemother., 52: 1244-1251.
3. Ammari, L.K., J.M. Puck and K.L. McGowan, 1993. Catheter-related Fusarium solani fungemia and pulmonary infection in a patient with leukemia in remission. Clin. Infect. Dis., 16: 148-150.
4. Anaissie, E., H. Kantarjian, P. Jones, B. Barlogie, M. Luna, G. Lopez-Berestein and G.P. Bodey, 1986. Fusarium: A newly recognized fungal pathogen in immunosuppressed patients. Cancer, 57: 2141-2145.
5. Anaissie, E., H. Kantarjian, J. Ro, R. Hopfer, K. Rolston, V. Fainstein and G. Bodey, 1988. The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore), 67: 77-83.
6. Anaissie, E.J., G.P. Bodey and M.G. Rinaldi, 1989. Emerging fungal pathogens. Eur. J. Clin. Microbiol. Infect. Dis., 8: 323-330.
7. Anaissie, E.J., R.T. Kuchar, J.H. Rex, A. Francesconi and M. Kasai et al., 2001. Fusariosis associated with pathogenic Fusarium species colonization of a hospital water system: A new paradigm for the epidemiology of opportunistic mold infections. Clin. Infect. Dis., 33: 1871-1878.
8. Anaissie, E.J., S.L. Stratton, M.C. Dignani, C.K. Lee and T.H. Mahfouz et al., 2002. Cleaning patient shower facilities: A novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. Clin. Infect. Dis., 35: 86-88.
9. Arikan, S., M. Lozano-Chiu, V. Paetznick and J.H. Rex, 2000. In vitro synergy studies with caspofungin and amphotericin B against Aspergillus and Fusarium. Proceedings of 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Sept. 17-20, Hacettepe University, Ankara, Turkey, pp: 368-368.
10. Austen, B., H. McCarthy, B. Wilkins, A. Smith and A. Duncombe, 2001. Fatal disseminated Fusarium infection in acute lymphoblastic leukaemia in complete remission. J. Clin. Pathol., 54: 488-490.
11. Azor, M., J. Gené, J. Gane and J. Guarro, 2007. Universal in vitro antifungal resistance of genetic clades of the Fusarium solanispecies complex. Antimicrob. Agents Chemother., 51: 1500-1503.
12. Azor, M., J. Gené, J. Gane, D.A. Sutton, A.W. Fothergill, M.G. Rinaldi and J. Guarro, 2008. In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum. Antimicrob. Agents Chemother., 52: 2228-2231.
13. Balajee, S.A., A.M. Borman, M.E. Brandt, J. Cano and M. Cuenca-Estrella et al., 2009. Sequence- based identification of Aspergillus, Fusarium and Mucorales Species in the clinical mycology laboratory: Where are we and where should we go from here? J. Clin. Microbial., 47: 877-884.
14. Barrios, N.J., D.V. Kirkpatrick, A. Murciano, K. Stine, R.B. van Dyke and J.R. Humbert, 1990. Successful treatment of disseminated Fusarium infection in an immunocompromised child. Am. J. Pediatr. Hematol. Oncol., 12: 319-324.
15. Behrens-Baumann, W., 1999. Mycosis of the Eye and its Adnexa. In: Developments in Ophthalmology, Behrens-Baumann, W. (Ed.). Vol. 32. Karger Publisher, Basel, Switzerland, pp: 201.
16. Betina, V., 1984. Mycotoxins: Production, Isolation, Separation and Purification. Developments in Food Science-8. Elsevier Publication, Amsterdam, pp: 155.
17. Bhat, R.V., S.R. Beedu, Y. Ramakrishna and K.L. Munshi, 1989. Outbreak of trichothecene mycotoxicosis associated with consumption of mould damaged wheat in Kashmir Valley, India. Lancet, 333: 35-37.
18. Bigley, V.H., R.F. Duarte, R.D. Gosling, C.C. Kibbler, S. Seaton and M. Potter, 2004. Fusarium dimerum infection in a stem cell transplant recipient treated successfully with voriconazole. Bone Marrow Transplantation, 34: 815-817.
19. Boutati, E.I. and E.J. Anaissie, 1997. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: Ten years experience at a cancer center and implications for management. Blood, 90: 999-1008.
20. Burgess, L.W., 1981. General Ecology of the Fusaria. In: Fusarium: Diseases, Biology and Taxonomy, Nelson, P.E., T.A. Toussoun and R.J. Cook (Eds.). Pennsylvania State University Press, Philadelphia, PA, pp: 225-235.
21. Castagnola, E., A. Garaventa, M. Conte, A. Barretta, E. Faggi and C. Viscoli, 1993. Survival after fungemia due to Fusarium moniliforme in a child with neuroblastoma. Eur. J. Clin. Microbial. Infect. Dis., 12: 308-309.
22. CLSI, 2008. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. 2nd Edn., Clinical and Laboratory Standards Institute, Wayne, PA.
23. Cruse, M., R. Telerant, T. Gallagher, T. Lee and J.W. Taylor, 2002. Cryptic species in Stachybotrys chartarum. Mycologia, 94: 814-822.
24. Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, G. Garcia-Effron, A. Monzon and J.L. Rodriguez-Tudela, 2005. In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi. Antimicrob. Agents Chemother., 49: 5136-5138.
25. Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, M.J. Buitrago, A. Monzon and J.L. Rodriguez-Tudela, 2006. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob. Agents Chemother., 50: 917-921.
26. De la Camp al, R., D.C. Hooker, J.D. Miller, A.W. Schaafsma and B.G. Hammond, 2005. Modeling effects of environment, insect damage and Bt genotypes on fumonisin accumulation in maize in Argentina and the Philippines. Mycopathologia, 159: 539-552.
27. De Hoag, G.S., J. Guarro, J. Gene and M.J. Figueras, 2000. Atlas of Clinical Fungi. 2nd Edn., Vol. 1. ASM Press, Utrecht, The Netherlands.
28. Di Pietro, A., M.P. Madrid, Z. Caracuel, J. Delgado-Jarana and M.I.G. Roncero, 2003. Fusarium oxysporum: Exploring the molecular arsenal of a vascular wilt fungus. Mol. Plant Pathol., 4: 315-325.
29. Dignani, M.C. and E.J. Anaissie, 2004. Human fusariosis. Clin. Microbial. Infect., 10: 67-75.
30. Durand-Joly, I., S. Alfandari, Z. Benchikh, M. Rodrigue and A. Espinel-Ingroff et al., 2003. Successful outcome of disseminated Fusarium infection with skin localization treated with voriconazole and amphotericin B-lipid complex in a patient with acute leukemia. J. Clin. Microbial., 41: 4898-4900.
31. Dursun, D., V. Fernandez, D. Miller and E.C. Alfonso, 2003. Advanced Fusarium keratitis progressing to endophthalmitis. Cornea, 22: 300-303.
32. Eljaschewitsch, J., J. Sandfort, K. Tintelnot, I. Horbach and B. Ruf, 1996. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: Treatment with liposomal amphotericin B. Mycoses, 39: 115-119.
33. Elvers, K.T., K. Leeming, C.P. Moore and H.M. Lappin-Scott, 1998. Bacterial-fungal biofilms in flowing water photo-processing tanks. J. Appl. Microbiol., 84: 607-618.
34. Espinel-Ingroff, A.,V. Chaturvedi, A. Fothergill and M.G. Rinaldi, 2002. Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLs collaborative study. J. Clin. Microbial., 40: 3776-3781.
35. Espinel-Ingroff, A., 2003. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: Review of the literature. Rev. Iberoam. Micol., 20: 121-136.
36. Ferrer, C., J. Alio, A. Rodriguez, M. Andreu and F. Colom, 2005. Endophthalmitis caused by Fusarium proliferatum. J. Clin. Microbial., 43: 5372-5375.
37. Fleming, R.V., T.J. Walsh and E.J. Anaissie, 2002. Emerging and less common fungal pathogen. Infect Dis. Clin. N. Am., 16: 915-933.
38. Fukuzawa, M., H. Inaba, M. Hayama, N. Sakaguchi, K. Sano, M. Ito and M. Hotchi, 1995. Improved detection of medically important fungi by immunoperoxidase staining with polyclonal antibodies. Virchows Arch., 427: 407-414.
39. Gaviria, J.M., J.A. van Bunk, D.C. Dale, R.K. Root and W.C. Liles, 1999. Comparison of interferon- gamma, granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J. Infect. Dis., 179: 1038-1041.
40. Geiser, D.M., M.D. Jimenez-Gasco, S.C. Kang, I. Makalowska and N. Veeraraghavan et al., 2004. FUSARIUM-ID v. 1.0: A DNA sequence database for identifying Fusarium. Eur. J. Plant Pathol., 110: 473-479.
41. Gelderblom, W.C., K. Jaskiewicz, W.F. Marasas, P.G. Thiel, R.M. Horak, R. Vleggaar and N.P. Kriek, 1988. Fumonisins-novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Appl. Environ. Microbiol., 54: 1806-1811.
42. Gelderblom, W.C.A., E. Semple, W.F.O. Marasas and E. Farber, 1992. The cancer initiating potential of the fumonosin B1 mycotoxins. Carcinogenesis, 13: 433-437.
43. Gilgado, F., J. Cano, J. Gené and J. Guarro, 2005. Molecular phylogeny of the Pseudallescheria boydii species complex: Proposal of two new species. J. Clin. Microbiol., 43: 4930-4942.
44. Godoy, P., J. Cano, J. Gene, J. Guarro, A.L. Hofling-Lima and A.L. Colombo, 2004. Genotyping of 44 isolates of Fusarium solani, the main agent of fungal keratitis in Brazil. J. Clin. Microbiol., 42: 4494-4497.
45. Groff, A.H., T. Stergiopoulou, E. Roilides and T.J. Walsh, 2005. Micafungin: Pharmacology, experimental therapeutics and clinical applications. Exp. Opin. Invest. Drugs, 14: 489-509.
46. Guarro, J. and J. Gené, 1992. Fusarium infections. Criteria for the identification of the responsible species. Mycoses, 35: 109-114.
47. Guarro, J. and J. Gené, 1995. Opportunistic fusarial infections in human. Eur. J. Clin. Microbial. Infect. Dis., 14: 741-754.
48. Guarro, J., M. Nucci, T. Akiti, J. Gené, M.D. Barreiro and R.T. Gongalves, 2000. Fungemia due to Fusarium sacchari in an immunosuppressed patient. J. Clin. Microbiol., 38: 419-421.
49. Guarro, J., C. Rubio, J. Gené, J. Cano and J. Gil et al., 2003. Case of keratitis caused by an uncommon Fusarium species. J. Clin. Microbiol., 41: 5823-5826.
50. Guzman-Cottrill, J.A., X. Zheng and E.G. Chadwick, 2004. Fusarium solani endocarditis successfully treated with liposomal amphotericin B and voriconazole. Pediatr. Infect. Dis. J., 23: 1059-1061.
51. Hall, L., S. Wohlfiel and G.D. Roberts, 2004. Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of filamentous fungi encountered in the clinical laboratory. J. Clin. Microbiol., 42: 622-626.
52. Harrison, L.R., B.M. Colvin, J.T. Greene, L.E. Newman and J.R. Jr. Cole, 1990. Pulmonary edema and hydrothorax in swine produced by fumonisin Bl, a toxic metabolite of Fusarium moniliforme. J. Vet. Diag. Invest., 2: 217-221.
53. Healy, M., K. Reece, D. Walton, J. Huong, S. Frye, I.I. Raad and D.P. Kontoyiannis, 2005. Use of the diversi lab system for species and strain differentiation of Fusarium species isolates. J. Clin. Microbiol., 43: 5278-5280.
54. Helm, T.N., D.L. Longworth, G.S. Hall, B.J. Bolwell, B. Fernández and K.J. Tomecki, 1990. Case report and review of resolved fusariosis. J. Am. Acad. Dermatol., 23: 393-398.
55. Hennequin, C., V. Lavarde, J.L. Poirot, M. Rabodonirina and A. Datry et al., 1997. Invasive Fusarium infections: A retrospective survey of 31 cases. The french groupe d'Etudes des mycoses opportunistes. J. Med. Vet. Mycol., 35: 107-114.
56. Herbrecht, R., R. Kessler, C. Kravanja, M.H. Meyer, J. Waller and V. Letscher-Bru, 2004. Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient. J. Heart Lung Transplantion, 23: 1451-1454.
57. Hinrikson, H.P., S.F. Hurst, T.J. Lott, D.W. Warnock and C.J. Morrison, 2005. Assessment of ribosomal large-subunit D1-D2, internal transcribed spacer 1 and internal transcribed spacer 2 regions as targets for molecular identification of medically important Aspergillus species. J. Clin. Microbiol., 43: 2092-2103.
58. Howden, B.P., M.A. Slavin, A.P. Schwarer and A.M. Mijch, 2003. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur. J. Clin. Microbial. Infect. Dis., 22: 111-113.
59. IARC, 2002. IARC monographs on the evaluation of carcinogenic risks to humans. Some traditional herbal medicines, some mycotoxins, naphthalene and styrene. International Agency for Research on Cancer, pp: 301-366.
60. Jessup, C.J., N.S. Ryder and M.A. Ghannoum, 2000. An evaluation of the in vitro activity of terbinafine. Med. Mycol., 38: 155-159.
61. Jindal, N., S.K. Mahipal and G.E. Rottinghaus, 1999. Occurrence of fumonisin B1 in maize and poultry feeds in Haryana, India. Mycopathologia, 148: 37-40.
62. Kaufman, L., P.G. Standard, M. Jalbert and D.E. Kraft, 1997. Immunohistologic identification of Aspergillus sp. and other hyaline fungi by using polyclonal fluorescent antibodies. J. Clin. Microbial., 35: 2206-2209.
63. Kiehn, T.E., P.E. Nelson, E.M. Bernard, F.F. Edwards, B. Koziner and D. Armstrong, 1985. Catheter-associated fungemia caused by Fusarium ehlamydosporum in a patient with lymphocytic lymphoma. J. Clin. Microbiol., 21: 501-504.
64. Kratka, J. and E. Kovacikova, 1979. The effect of temperature and age of strains of Fusarium oxysporum on its enzymatic activity. Zentbl. Bakteriol. Naturwiss., 134: 154-158.
65. Krcmery, V. Jr., E. Kunova, Z. Jesenska, J. Trupl, S. Spanik, J. Mardiak, M. Studena and E. Kukuckova, 1996. Invasive mold infections in cancer patients: 5 years' experience with Aspergillus, Mucor, Fusarium and Acremonium infections. Support Care Cancer, 4: 39-45.
66. Krulder, J.W., R.W. Brimicombe, P.W. Wijermans and W. Gams, 1996. Systemic Fusarium nygamai infection in a patient with lymphoblastic non-Hodgkin's lymphoma. Mycoses, 39: 121-123.
67. Kurien, M., V. Anandi, R. Raman and K.N. Brahmadathan, 1992. Maxillary sinus fusariosis in immunocompetent hosts. J. Laryngol. Otol., 106: 733-736.
68. Larone, D.H., 1995. Medically Important Fungi-A Guide to Identification. 3rd Edn., ASM Press, Washington DC.
69. Legrand, C., E. Anaissie, R. Hashem, P. Nelson, G.P. Bodey and J. Ro, 1991. Experimental fusarial hyalohyphomycosis in a murine model. J. Infect. Dis., 164: 944-948.
70. Leslie, J.F. and B.A. Summerell, 2006. The Fusarium Laboratory Manual. Blackwell Publishing, State Avenue, Ames, Iowa, USA.
71. Letscher-Bru, V., F. Campos, J. Waller, R. Randriamahazaka, E. Candolfi and R. Herbrecht, 2002. Successful outcome of treatment of a disseminated infection due to Fusarium dimerum in a leukemia patient. J. Clin. Microbiol., 40: 1100-1102.
72. Liu, K., D.N. Howell, J.R. Perfect and W.A. Schell, 1998. Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces and Acremonium species by histopathology. Am. J. Clin. Pathol., 109: 45-54.
73. Lopes, J.O., E.S. de Mello and C. Mock, 1995. Mixed intranasal infection caused by Fusarium solani and a zygomycete in a leukaemic patient. Mycoses, 38: 281-284.
74. Lupinetti, F.M., R.H. Giller and M.E. Trigg, 1990. Operative treatment of Fusarium fungal infection of the lung. Ann. Thoracic Surgery, 49: 991-992.
75. Makowsky, M.J., D.I. Warkentin and M.L. Savoie, 2005. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia. Ann. Pharmacother., 39: 1365-1366.
76. Marasas, W.F.O., T.S. Kellerman, J.G. Pienaar and T.W. Naude, 1976. Leukoencephalomalacia: A mycotoxicosis of Equidae caused by Fusarium moniliforme Sheldon. onderstepoort J. Vet. Res., 43: 113-122.
77. Marasas, W.F., 2001. Discovery and occurrence of the fumonisins: A historical perspective. Environ. Health Perspect., 71: 239-243.
78. Marr, K.A. and R.A. Bowden, 1999. Fungal infections in patients undergoing blood and marrow transplantation. Transplant. Infect. Dis., 1: 237-246.
79. Marr, K.A., R.A. Carter, F. Crippa, A. Wald and L. Corey, 2002. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin. Infect. Dis., 34: 909-917.
80. Martino, P., R. Gastaldi, R. Raccah and C. Girmenia, 1994. Clinical patterns of Fusarium infections in immunocompromised patients. J. Infect., 28: 7-15.
81. Mayayo, E., I. Pujol and J. Guarro, 1999. Experimental pathogenicity of four opportunist Fusarium species in a murine model. J. Med. Microbiol., 48: 363-366.
82. McMullen, M.P., R. Jones and D. Gallenberg, 1997. Scab of wheat and barley: A re-emerging disease of devastating impact. Plant Dis., 81: 1340-1348.
83. Melcher, G.P., D.A. McGough, A.W. Fothergill, C. Norris and G. Rinaldi, 1993. Disseminated hyalohyphomycosis caused by a novel human pathogen, Fusarium napiforme. J. Clin. Microbiol., 31: 1461-1467.
84. Meletiadis, J., J.F.G.M. Meis, J.W. Mouton, J.P. Donnelly and P.E. Verweij, 2000. Comparison of NCCLS and 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MT T) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J. Clin. Microbiol., 38: 2949-2954.
85. Merz, W.G., J.E. Karp, M. Hoagland, M. Jett-Goheen, J.M. Junknis and A.F. Hood, 1988. Diagnosis and successful treatment of fusariosis in the compromised host. J. Infect. Dis., 158: 1046-1055.
86. Mitter, N., A.C. Srivastava, S. Renu, A.K. Ahmad, Sarbhoy and D.K. Agarwa, 2002. Characterization of gibberellin producing strains of Fusarium moniliforme based on DNA polymorphism. Mycopathologia, 153: 187-193.
87. Morooka, N., N. Uratsuji, T. Yoshizawa and H. Yamamoto, 1972. Studies on the toxic substances in barley infected with Fusarium sp. J. Food Hyg. Soc. Jap., 13: 368-375.
88. Musa, M.O., A. Al-Eisa, M. Halim, E. Sahovic and M. Gyger et al., 2000. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: A single institution experience over 10 years. Br. J. Haematol., 108: 544-548.
89. Nelson, P.E., T.A. Toussoun and W.F.O. Marasas, 1983. Fusarium Species: An Illustrated Manual for Identification. The Pennsylvania State University Press, University Park, USA.
90. Nelson, P.E., M.C. Dignani and E.J. Anaissie, 1994. Taxonomy, biology and clinical aspects of Fusarium species. Clin. Microbiol. Rev., 7: 479-504.
91. Neuburger, S., G. Massenkeil, M. Seibold, C. Lutz and I. Tamm et al., 2008. Successful salvage treatment of disseminated cutaneous fusariosis with liposomal amphotericin B and terbinafine after allogeneic stem cell transplantation. Transplant Infect. Dis., 10: 290-293.
92. Nilsson, R.H., M. Ryberg, E. Kristiansson, K. Abarenkov, K. Larsson and U. KOljalg, 2006. Taxonomic reliability of DNA sequences in public sequence databases: A fungal perspective. PloS One, 1: 59-59.
93. Nir-Paz, R., J. Strahilevitz, M. Shapiro, N. Keller and A. Goldschmied-Reouven et al., 2004. Clinical and epidemiological aspects of infections caused byFusarium species: A collaborative study from Israel. J. Clin. Microbiol., 42: 3456-3461.
94. Nirenberg, H.I. and K. O'Donnell, 1998. New Fusarium species and combinations within the Gibberella fujikuroi species complex. Mycologia, 90: 434-458.
95. Norred, W.P., 1993. Fumonisins-mycotoxins produced by Fusarium moniliforme. J. Toxicol. Environ. Health, 38: 309-328.
96. Nucci, M., N. Spector, S. Lucena, P.C. Bacha and W. Pulcheri et al., 1992. Three cases of infection with Fusarium species in neutropenic patients. Eur. J. Clin. Microbiol. Infect. Dis., 11: 1160-1162.
97. Nucci, M. and E. Anaissie, 2002. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: Implications for diagnosis and management. Clin. Infect. Dis., 35: 909-920.
98. Nucci, M., E.J. Anaissie, F. Queiroz-Telles, C.A. Martins and P. Trabasso et al., 2003. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer, 98: 315-319.
99. Nucci, M., K.A. Marr, F. Queiroz-Telles, C.A. Martins and P. Trabasso et al., 2004. Fusarium infection in hematopoietic stem cell transplant recipients. Clin. Infect. Dis., 38: 1237-1242.
100. Nucci, M. and E. Anaissie, 2007. Fusarium infections in immunocompromised patients. Clin. Microbiol. Rev., 20: 695-704.
101. Odabasi, Z., G. Mattiuzzi, E. Estey, H. Kantarjian and F. Saeki et al., 2004. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis., 39: 199-205.
102. Ortoneda, M., J. Guarro, M.P. Madrid, Z. Caracuel, M.I.G. Roncero, E. Mayayo and A.D. Pietro, 2004. Fusarium oxysporum as multihost model for the genetic dissection of fungal virulence in plants and animals. Infect. Immun., 72: 1760-1766.
103. Ostrosky-Zeichner, L., B.D. Alexander, D.H. Kett, J. Vazquez and P.G. Pappas et al., 2005. Multicenter clinical evaluation of the (13) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis., 41: 654-659.
104. O'Donnell, K. and E. Cigelnik, 1997. Two divergent intragenomic rADN ITS2 types within a monophyletic lineage of the fungus Fusarium are nonorthologous. Mol. Phylogenet. Evol., 7: 103-116.
105. O'Donnell, K., E. Cigelnik and H.I. Nirenberg, 1998. Molecular systematics and phylogeography of the Gibberella fujikuroi species complex. Mycologia, 90: 465-493.
106. O'Donnell, K., 2000. Molecular phylogeny of the Nectria haematococca-Fusarium solani species complex. Mycologia, 92: 919-938.
107. O'Donnell, K., H.I. Nirenberg, A. Takayuki and E. Cigelnik, 2000. A multigene phylogeny of the Gibberella fujikuroi species complex: Detection of additional phylogenetically distinct species. Mycoscience, 41: 61-78.
108. O'Donnell, K., D.A. Sutton, M.G. Rinaldi, K.C. Magnon and P.A. Cox et al., 2004. Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: Evidence for the recent dispersion of a geographically widespread clonal lineage and nosocomial origin. J. Clin. Microbiol., 42: 5109-5120.
109. O'Donnell, K., B.A.J. Sarver, M. Brandt, D.C. Chang and J. Noble-Wang et al., 2007. Phylogenetic diversity and microsphere array-based genotyping of human pathogenic fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006. J. Clin. Microbial., 45: 2235-2248.
110. O'Donnell, K., D.A. Sutton, A. Fothergill, D. McCarthy and M.G. Rinaldi et al., 2008. Molecular phylogenetic diversity, multilocus haplotype nomenclature and in vitro antifungal resistance within the Fusarium solani species complex. J. Clin. Microbiol., 46: 2477-2490.
111. Paphitou, N.I., L. Ostrosky-Zeichner, V.L. Paetznick, J.R. Rodriguez, E. Chen and J.H. Rex, 2002. In vitro activities of investigational triazoles against Fusarium species: Effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob. Agents Chemother., 46: 3298-3300.
112. Pastor, F.J. and J. Guarro, 2007. El papel del voriconazol en el tratamiento de las micosis emergentes. Rev. Iberoam. Micol., 24: 228-232.
113. Pennisi, E., 2008. DNA data. Proposal to Wikify' GenBank meets stiff resistance. Science, 319: 1598-1599.
114. Pfaller, M.A. and D.J. Diekema, 2004. Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol., 42: 4419-4431.
115. Pitt, J.I., A.D. Hocking, K. Budhasamai, B.F. Miscamble, K.A. Wheeler and P. Tanboon-Ek, 1994. The normal mycoflora of commodities from Thailand.2. Beans, rice, small grains and other commodities. Int. J. Food Microbiol., 23: 35-53.
116. Placinta, C.M., J.P.F. D'Mello and A.M.C. Macdeoxynivalenolald, 1999. A review of worldwide contamination of cereal grains and animal feed with Fusarium mycotoxins. Anim. Feed Sci. Technol., 78: 21-37.
117. Poirot, J.L., J.P. Laporte, E. Gueho, A. Verny and N.C. Gorin et al., 1985. Deep mycosis caused by Fusarium. Presse Med., 14: 2300-2301.
118. Ponton, J., R. Ruchel, K.V. Clemons, D.C. Coleman and R. Grillot et al., 2000. Emerging pathogens. Med. Mycol., 38: 225-236.
119. Prathapkumar, S.H., V.S. Rao, R.J. Paramkishan and R.V. Bhat, 1997. Disease outbreak in laying hens arising from the consumption of fumonisin contaminated food. Br. Poult. Sci., 38: 475-479.
120. Pujol, I., J. Guarro, J. Gené and J. Sala, 1997. In vitro antifungal susceptibility of clinical and environmental Fusarium sp. strains. J. Antimicrob. Chemother., 39: 163-167.
121. Raad, I. and R. Hachem, 1995. Treatment of central venous catheter-related fungemia due to Fusarium oxysporum. Clin. Infect. Dis., 20: 709-711.
122. Raad, I., J. Tarrand, H. Hanna, M. Albitar and E. Janssen et al., 2002. Epidemiology, molecular mycologyand environmental sources of Fusarium infection in patients with cancer. Infect. Control Hospital Epidemiol., 23: 532-537.
123. Rabodonirina, M., M.A. Piens, M.F. Monier, E. Guého, D. Fière and M. Mojon, 1994. Fusarium infections in immunocompromised patients: Case reports and literature review. Eur. J. Clin. Microbiol. Infect. Dis., 13: 152-161.
124. Rezai, K.A., D. Eliott, O. Plous, J.A. Vazquez and G.W. Abrams, 2005. Disseminated Fusarium infection presenting as bilateral endogenous endophthalmitis in a patient with acute myeloid leukemia. Arch. Ophthalmol., 123: 702-703.
125. Richardson, S.E., R.M. Bannatyne, R.C. Summerbell, J. Milliken, R. Gold and S.S. Weitzman, 1988. Disseminated fusarial infection in the immunocompromised host. Rev. Infect. Dis., 10: 1171-1181.
126. Rodriguez, C.A., J. Lujan-Zilbermann, P. Woodard, M. Andreansky and E.E. Adderson, 2003. Successful treatment of disseminated fusariosis. Bone Marrow Transplantation, 31: 411-412.
127. Romani, L., 2004. Immunity to fungal infections. Nat. Rev. Immunol., 4: 1-24.
128. Rothe, A., M. Seibold, T. Hoppe, H. Seifert and A. Engert et al., 2004. Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann. Hematol., 83: 394-397.
129. Sampath, K.P. and C.V. Paya, 2001. Fusarium infection after solid-organ transplantation. Clin. Infect. Dis., 32: 1237-1240.
130. Schwarz, P., S. Bretagne, J.C. Gantier, D. Garcia-Hermoso, O. Lortholary, F. Dromer and E. Dannaoui, 2006. Molecular identification of zygomycetes from culture and experimentally infected tissues. J. Clin. Microbiol., 44: 340-349.
131. Segal, B.H., T.J. Walsh, J.M. Liu, J.D. Wilson and K.J. Kwon-Chung, 1998. Invasive Infection with Fusarium chlamydosporum in a Patient with aplastic anemia. J. Clin. Microbiol., 36: 1772-1776.
132. Seifert, K.A., T. Aoki, R.P. Baayen, D. Brayford and L.W. Burgess et al., 2003. The name Fusarium moniliforme should no longer be used. Mycol. Res., 107: 643-644.
133. Sekhon, A.S., L. Kaufman, N. Moledina, R.C. Summerbell, A.A. Padhye, E.A. Ambroisie and T. Panter, 1995. An exoantigen test for the rapid identification of medically significant Fusarium species. J. Med. Vet. Mycol., 33: 287-289.
134. Shoham, S. and S.M. Levitz, 2005. The immune response to fungal infections. Br. J. Haematol., 129: 569-582.
135. Spielberger, R.T., M.J. Falleroni, A.J. Coene and R.A. Larson, 1993. Concomitant amphotericin B therapy, granulocyte transfusions and GM-CSF administration for disseminated infection with Fusarium in a granulocytopenic patient. Clin. Infect. Dis., 16: 528-530.
136. Stockmann-Juvala, H. and K. Savolainen, 2008. A review of the toxic effects and mechanisms of action of fumonisin Bl. Hum. Exp. Toxicol., 27: 799-809.
137. Summerbell, R.C., S.E. Richardson and J. Kane, 1988. Fusarium proliferatum as an agent of disseminated infection in an immunosuppressed patient. J. Clin. Microbiol., 26: 82-87.
138. Sutton, D.A., A.W. Fothergill and M.G. Rinaldi, 1998. Guide to Clinically Significant Fungi. 1st Edn., Williams and Wilkins, Baltimore.
139. Swofford, D.L., 2001. PAUP*: Phylogenetic Analysis Using Parsimony (*and other methods), Version 4.0b8. Sinauer Associates, Sunderland, MA., USA.
140. Szekely, A., E.M. Johnson and D.W. Warnock, 1999. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J. Clin. Microbiol., 37: 1480-1483.
141. Thomas, P.A., 2003. Current perspectives on ophthalmic mycoses. Clin. Microbiol. Rev., 16: 730-797.
142. Tiribelli, M., F. Zaja, C. Fili, T. Michelutti, S. Prosdocimo, A. Candoni and R. Fanin, 2002. Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia. Eur. J. Haematol., 68: 314-317.
143. Tortorano, A.M., A. Prigitano, G. Dho, M.C. Esposto and C. Gianni et al., 2008. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium sp. from Northern Italy. Antimicrob. Agents Chemother., 52: 2683-2685.
144. Ueno, Y., 1983. Trichothecenes-Clinical, Biological and Toxicological Aspects. Kodansha Ltd., Tokyo, pp: 1-6.
145. Vakdevi, V., K. Rupula, S.R. Beedu and V. Deshpande, 2009. Purification and characterization of mycoferritin from Fusarium verticillioides. BioMetals, 22: 1063-1073.
146. Valenstein, P. and W.A. Schell, 1986. Primary intranasal Fusarium infection. Potential for confusion with rhinocerebral zygomycosis. Arch. Pathol. Lab. Med., 110: 751-754.
147. Vartivarian, S.E., E.J. Anaissie and G.P. Bodey, 1993. Emerging fungal pathogens in immunocompromised patients: Classification, diagnosis and management. Clin. Infect. Dis., 17: 487-491.
148. Velasco, E., C.A. Martins and M. Nucci, 1995. Successful treatment of catheter-related fusarial infection in immunocompromised children. Eur. J. Clin. Microbiol. Infect. Dis., 14: 697-699.
149. Vesonder, R.F., A. Ciegler and A.H. Jensen, 1973. Isolation of the emetic principle from Fusarium infected corn. Appl. Microbiol., 26: 1008-1010.
150. Vesonder, R.F., J.J. Ellis and W.K. Rohwedder, 1981. Elaboration of vomitoxin and zearalenone by Fusarium isolates and the biological activity of Fusarium-produced toxins. Appl. Environ. Microbiol., 42: 1132-1134.
151. Vismer, H.F., W.F.O. Marasas, J.P. Rheeder and J.J. Joubert, 2002. Fusarium dimerum as a cause of human eye infection. Med. Mycol., 40: 399-406.
152. Voss, K.A., G.W. Smith and W.M. Haschek, 2007. Fumonisins: Toxicokinetics, mechanism of action and toxicity. Anim. Feed Sci. Technol., 137: 299-325.
153. White, T.J., T. Bruns, S. Lee and J. Taylor, 1990. Amplification and Direct Sequencing of Fungal Ribosomal RNA Genes for Phylogenetics. In: PCR Protocols: A Guide to Methods and Applications, Innis, M., D. Gefal, J. Sninsky and T. White (Eds.). Academic Press, London, UK., pp: 315-322.
154. Wickern, G.M., 1993. Fusarium allergic fungal sinusitis. J. Allergy Clin. Immunol., 92: 624-625.
155. Williams, R.J. and D. McDonald, 1983. Grain molds in the tropics: Problem and importance. Annu. Rev. Phytopathol., 21: 153-158.
156. Winn, R.M., C. Gil-Lamaignere, E. Roilides, M. Simitsopoulou, C.A. Lyman, A. Maloukou and T.J. Walsh, 2005. Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium sp. and Scedosporium sp. Cytokine, 31: 1-8.
157. Zapater, R.C., 1986. Opportunistic fungus infections. Fusarium infections (keratomycosis by Fusarium). Jap. J. Med. Mycol., 27: 68-69.
158. Zhang, N., K. O'Donnell, D.A. Sutton, F.A. Nalim, R.C. Summerbell, A.A. Padhye and D.M. Geiser, 2006. Members of the Fusarium solani species complex that cause infections in both humans and plants are common in the environment. J. Clin. Microbial., 44: 2186-2190.